Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Peter C. Farrell, a director at ResMed Inc, plans to sell 2,000 common shares of the company on the NYSE, with an aggregate market value of $500,000, as part of a routine stock option transaction. This announcement follows Farrell’s recent sales of similar share amounts over the past few months, reflecting a strategic divestment approach. Investors may find these transactions insightful for evaluating insider trading activities within the company.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Weighs in on Robinhood Stock Amid Soaring Trading Volumes
- M&A News: Paramount (NASDAQ:PARA) Deal May Face Risk With Trump Administration
- Ford (NYSE:F) Notches Up as EV Motor Production Begins
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
